Cargando…

New Biomarkers for Early Detection of Hepatocellular Carcinoma

Detalles Bibliográficos
Autor principal:	Yoshida, Katsunori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486194/ https://www.ncbi.nlm.nih.gov/pubmed/26137579 http://dx.doi.org/10.1016/j.ebiom.2015.04.001

Ejemplares similares

Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma
por: He, Jian, et al.
Publicado: (2016)

Somatic copy number aberrations detected in circulating tumor DNA can hold diagnostic value for early detection of hepatocellular carcinoma
por: Chatzaki, Ekaterini, et al.
Publicado: (2020)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

A new era for hepatocellular carcinoma
por: Memeo, Riccardo, et al.
Publicado: (2023)

Utility of miRNA biomarkers for detection of early head and neck squamous cell carcinoma
por: Ershadifar, Soroush, et al.
Publicado: (2023)

Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
por: Balaceanu, Lavinia Alice
Publicado: (2019)

New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy
por: Numata, Kauzshi, et al.
Publicado: (2022)

Peptide vaccines for hepatocellular carcinoma
por: Nobuoka, Daisuke, et al.
Publicado: (2013)

Tivozanib for hepatocellular carcinoma: not likely a new option
por: Estrade, Florian, et al.
Publicado: (2020)

Cancer stem cells in hepatocellular carcinomas
por: Das, Prasenjit, et al.
Publicado: (2015)

Small nucleolar RNAs (snoRNAs) as potential non-invasive biomarkers for early cancer detection
por: Chen, Wen-Dan, et al.
Publicado: (2013)

Combination of biomarkers for the detection of hepatocellular carcinoma
por: Sternby Eilard, Malin, et al.
Publicado: (2020)

The detection of donor-derived cell-free DNA may serve as a biomarker for the early detection of chronic lung allograft dysfunction
por: Bansal, Sandhya, et al.
Publicado: (2019)

Gamma delta T cells in hepatocellular carcinoma: Sunrise of new therapy based on Vδ2 T cells?
por: Macek Jilkova, Zuzana
Publicado: (2022)

Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Revisit the signatures of γδ T cells in hepatocellular carcinoma
por: Gao, Yanan, et al.
Publicado: (2022)

Approach to systemic therapy in advanced hepatocellular carcinoma
por: Sankar, Kamya, et al.
Publicado: (2022)

MAP9/ERCC3 signaling cascade: A new insight on understanding the chromosomal instability in hepatocellular carcinoma
por: Mok, Etienne Ho Kit, et al.
Publicado: (2020)

Hepatocellular carcinoma therapy finds a channel on the radio
por: Camacho, Javier
Publicado: (2019)

Hepatocellular carcinoma: H-Prune gene regulatory networks
por: de Antonellis, Pasqualino
Publicado: (2019)

The Potential Implication of the Autonomic Nervous System in Hepatocellular Carcinoma
por: Parent, Romain, et al.
Publicado: (2019)

IL-11 drives postsurgical hepatocellular carcinoma recurrence
por: Lauko, Adam, et al.
Publicado: (2019)

Evidence-based medicine and Management of Hepatocellular Carcinoma in Thalassemia
por: Mancuso, Andrea
Publicado: (2020)

Hepatocellular carcinoma: development and early detection
por: Robinson, Philip
Publicado: (2008)

VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma
por: Takaya, Hiroaki, et al.
Publicado: (2019)

Potential targets for molecular imaging of apoptosis resistance in hepatocellular carcinoma
por: Liu, Z, et al.
Publicado: (2011)

The synergistic effect of sorafenib and TNF-α inhibitor on hepatocellular carcinoma
por: Wang, Mingda, et al.
Publicado: (2019)

Commentary: Hepatocellular carcinoma: A threat for patients with Fontan circulation
por: Contreras, Juan, et al.
Publicado: (2020)

Lenvatinib in elderly hepatocellular carcinoma patients, a new therapeutic option in first line
por: Roth, Gael S., et al.
Publicado: (2020)

Bridging the Gap Between Sorafinib Efficacy and Effectiveness in Advanced Hepatocellular Carcinoma
por: Nipp, Ryan, et al.
Publicado: (2016)

miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics
por: Fu, Xiao, et al.
Publicado: (2018)

Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor
por: Musso, Orlando, et al.
Publicado: (2019)

Commentary: Hepatocellular carcinoma after the Fontan operation: Are we paying attention?
por: Burkhart, Harold M., et al.
Publicado: (2020)

An acid trip activates protumoral macrophages to promote hepatocellular carcinoma malignancy
por: Graham, Nicola, et al.
Publicado: (2022)

Beyond management to conquer life-threatening tumor thrombosis in hepatocellular carcinoma
por: Koga, Hironori
Publicado: (2022)

Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials
por: Ozer, Muhammet, et al.
Publicado: (2023)

Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
por: Ocker, Matthias
Publicado: (2018)

Identification of New Biomarker for Prediction of Hepatocellular Carcinoma Development in Early-Stage Cirrhosis Patients
por: Ning, Gang, et al.
Publicado: (2021)

Gut-microbiome Taxonomic Profiling as Non-invasive Biomarkers for the Early Detection of Alcoholic Hepatocellular Carcinoma
por: Seok, Jun, et al.
Publicado: (2020)

Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma
por: Ju, Hye-Lim, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7cpkhpo407ei9kcmvpoqhoh1ut